当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
VEKLURY (remdesivir)
药品名称
VEKLURY (remdesivir)
承诺描述
Conduct a clinical trial to evaluate the pharmacokinetics and safety of remdesivir in subjects with mild, moderate, and severe renal impairment to inform appropriate dosage recommendations in patients with COVID-19 with impaired renal function.